Press Releases
Adocia announces the initiation of a clinical trial on its combination of the long-acting insulin Glargine and a fast-acting insulin analog
This phase I/II clinical trial on Type I Diabetics seeks to compare the performance of this Combo based on insulin Glargine with HumalogMix(R). ...
Press Releases
Avedro Announces the Start of Two New US FDA Trials for Accelerated Cross-linking
Avedro Inc. a Boston-based ophthalmic medical device and pharmaceutical company announces today that the first patients have been treated in two new US clinical trials:...
Press Releases
Promethera Biosciences successfully enrols twenty patients in its multicentric phase I/II trial
Promethera Biosciences has conducted the trial in Belgium, France, United Kingdom, Italy and Israel, treating twenty patients affected by very rare liver-based metabolic diseases. ...
Press Releases
Neuroptis Biotech announces the preclinical results for its dry eye product ML7
Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is...
Press Releases
Advanced research instrumentation pioneer Oxford Optronix launches HypoxyLab™ – the industry’s first benchtop, HEPA-filtered hypoxia workstation
Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces the formal launch of HypoxyLab™ –...
Press Releases
PathoQuest and Covance to offer Next-Generation Sequencing-based biosafety assessments
Covance Inc. , one of the world's largest and most comprehensive drug development companies, and PathoQuest, a pioneer in the field of pathogen detection, today...
Press Releases
Trophos completes pivotal phase II/III study of olesoxime in Spinal Muscular Atrophy (SMA)
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.